{"companyId":277508,"requestedLanguage":"ja","resolvedLanguage":"ja","availableLanguages":["en","ja"],"companyName":"バイオラインRx株式会社","headOfficeLocation":"モディイン、イスラエル","presidentName":"フィリップ・A・サーリン","companySummary":null,"stockCode":"BLRX","currency":"USD","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["biolinerx.com"],"businessContents":["臨床段階のバイオ医薬品の開発","腫瘍学と希少疾患治療薬のライセンス供与"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://biolinerx.com/about/","scoreAbout":500,"scoreBusiness":300,"scoreGroup":0,"scoreCustomer":0}]}